SMARCA4 was found to maintain gliomas in an undifferentiated stem cell state, regulate genes involved in cell growth and extracellular matrix, and promote tumor growth in vivo in an H3K27M-dependent manner [136,137]. Here, SMARCA4 is linked to central nervous system cancer.